1735TiP NETTER-3: A phase III study of [177Lu]Lu-DOTA-TATE in patients with newly diagnosed, grade 1 and grade 2 (Ki-67<10%) advanced gastroenteropancreatic neuroendocrine tumors and high disease burden.
Saved in:
| Title: | 1735TiP NETTER-3: A phase III study of [177Lu]Lu-DOTA-TATE in patients with newly diagnosed, grade 1 and grade 2 (Ki-67<10%) advanced gastroenteropancreatic neuroendocrine tumors and high disease burden. |
|---|---|
| Authors: | Singh, S.1 (AUTHOR), Capdevila, J.2 (AUTHOR), Halfdanarson, T.R.3 (AUTHOR), Halperin, D.4 (AUTHOR), Herrmann, K.5 (AUTHOR), Pavel, M.E.6 (AUTHOR), Xu, J.7 (AUTHOR), Pathak, D.8 (AUTHOR), Kunz, P.L.9 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS1020-S1020. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 189420149 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 1735TiP NETTER-3: A phase III study of [177Lu]Lu-DOTA-TATE in patients with newly diagnosed, grade 1 and grade 2 (Ki-67<10%) advanced gastroenteropancreatic neuroendocrine tumors and high disease burden. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Singh%2C+S%2E%22">Singh, S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Capdevila%2C+J%2E%22">Capdevila, J.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Halfdanarson%2C+T%2ER%2E%22">Halfdanarson, T.R.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Halperin%2C+D%2E%22">Halperin, D.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Herrmann%2C+K%2E%22">Herrmann, K.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pavel%2C+M%2EE%2E%22">Pavel, M.E.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xu%2C+J%2E%22">Xu, J.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pathak%2C+D%2E%22">Pathak, D.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kunz%2C+P%2EL%2E%22">Kunz, P.L.</searchLink><relatesTo>9</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2025 Supplement 2, Vol. 36, pS1020-S1020. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189420149 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2025.08.2363 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S1020 Titles: – TitleFull: 1735TiP NETTER-3: A phase III study of [177Lu]Lu-DOTA-TATE in patients with newly diagnosed, grade 1 and grade 2 (Ki-67<10%) advanced gastroenteropancreatic neuroendocrine tumors and high disease burden. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Singh, S. – PersonEntity: Name: NameFull: Capdevila, J. – PersonEntity: Name: NameFull: Halfdanarson, T.R. – PersonEntity: Name: NameFull: Halperin, D. – PersonEntity: Name: NameFull: Herrmann, K. – PersonEntity: Name: NameFull: Pavel, M.E. – PersonEntity: Name: NameFull: Xu, J. – PersonEntity: Name: NameFull: Pathak, D. – PersonEntity: Name: NameFull: Kunz, P.L. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2025 Supplement 2 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 36 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |